Effects of Eszopiclone on Sleep and Memory in Schizophrenia
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The investigators will test the hypothesis that the sleep medication, eszopiclone, can
normalize brain activity during sleep and improve memory in patients with schizophrenia. The
investigators will do this by measuring sleep and memory performance on two conditions
separated by one week: taking 3 mg of eszopiclone and taking placebo. The investigators will
study healthy subjects and chronic, medicated outpatients with schizophrenia.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Beth Israel Deaconess Medical Center Mclean Hospital